APHA
Back to Annual Meeting
 		APHA 2006 APHA
Back to Annual Meeting
APHA Scientific Session and Event Listing
Session: The Future of Drug Safety: Promoting and Protecting the Health of the Public report from the Institute of Medicine Committee on the Assessment of the U.S. Drug Safety System
3088.1: Monday, November 06, 2006: 10:30 AM-12:00 PM
Oral
The Future of Drug Safety: Promoting and Protecting the Health of the Public report from the Institute of Medicine Committee on the Assessment of the U.S. Drug Safety System
In response to a growing concern with health risks posed by approved drugs, the IOM was asked by the Food and Drug Administration to form a panel of experts to study the U.S. drug safety system. Following an extensive review, the IOM panel released its report in Sept., 2006. This session will review the charge given to the IOM and the resulting recommendations made by its panel. The FDA perspective on the panel’s recommendations and the broader implications of the report on the agency and the U.S. drug safety system will also be discussed.
Learning Objectives: Refer to the individual abstracts for learning objectives
Panelist(s):Steven K. Galson, MD, MPH
Kathleen Stratton, PhD
Sa Edlavitch, PhD
Hugh Tilson, MD, DrPH
10:30 AMThe FDA Request to IOM - Steven Galson, MD, MPH
10:50 AMIOM Report: Process and Recommendations - Kathleen Stratton, PhD
11:10 AMFDA Perspective on the Findings and Recommendations - Steven Galson, MD, MPH
11:30 AMComments from the Practitioner - Hugh Tilson, MD, DrPH
11:45 AMDiscussion: Dr. Edlavitch, Panel, Audience
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:APHA

The 134th Annual Meeting & Exposition (November 4-8, 2006) of APHA